RIM
BPMC

RS Investment Management’s Blueprint Medicines BPMC Stock Holding History

RS Investment Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$15.8M Sell
777,880
-9,521
-1% -$173K 0.16% 207
2016
Q1 		$14.2M Buy
787,401
+47,091
+6% +$817K 0.14% 213
2015
Q4 		$19.5M Buy
740,310
+109,878
+17% +$2.47M 0.17% 182
2015
Q3 		$13.5M Buy
630,432
+137,922
+28% +$3.81M 0.12% 214
2015
Q2 		$13M Buy
+492,510
New +$14.1M 0.11% 228

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RS Investment Management's BPMC Position: Q2 2016 in Review

RS Investment Management reduced its Blueprint Medicines (BPMC) stake by 1.2% in Q2 2016, selling an estimated $173K and leaving 777,880 shares worth $15.8M. The position accounts for 0.16% of the portfolio, ranked #207.

RS Investment Management first reported a position in BPMC in Q2 2015 and has held it in 5 quarters since. The position peaked at $19.5M in Q4 2015. 82 funds tracked by Wall St. Rank hold BPMC as of Q2 2016.

  • RS Investment Management held 777,880 shares of Blueprint Medicines worth $15.8M as of Q2 2016.
  • RS Investment Management sold 9,521 Blueprint Medicines shares in Q2 2016, an estimated $173K.
  • Blueprint Medicines made up 0.16% of RS Investment Management's portfolio in Q2 2016, its #207 holding.
  • RS Investment Management first reported a position in Blueprint Medicines in Q2 2015 and has held it in 5 quarters since.
  • RS Investment Management's Blueprint Medicines position peaked at $19.5M in Q4 2015.
  • 82 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.